Latest news
Accelerated KT-621 Trial and Narrower Loss Might Change The Case For Investing In Kymera Therapeutics (KYMR) - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 07:15:26 GMTKymera Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 22:01:14 GMTKYMR: KT-621 and KT-579 advance rapidly, with $1.5B cash runway supporting late-stage pipeline - TradingViewTradingView · Wed, 05 Aug 2026 15:15:25 GMT